256 related articles for article (PubMed ID: 24612178)
1. New American College of Cardiology and American Heart Association cholesterol treatment guidelines: subjects with Type 2 diabetes are under treated with high-intensity statins.
Tripolt NJ; Sourij H
Diabet Med; 2014 Jul; 31(7):879-80. PubMed ID: 24612178
[No Abstract] [Full Text] [Related]
2. Cholesterol treatment and changes in guidelines in an academic medical practice.
Schoen MW; Salas J; Scherrer JF; Buckhold FR
Am J Med; 2015 Apr; 128(4):403-9. PubMed ID: 25460526
[TBL] [Abstract][Full Text] [Related]
3. The 2013 ACC/AHA guidelines on the treatment of blood cholesterol: questions, questions, questions.
Ginsberg HN
Circ Res; 2014 Feb; 114(5):761-4. PubMed ID: 24577964
[No Abstract] [Full Text] [Related]
4. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
Stone NJ; Robinson JG; Lichtenstein AH; Bairey Merz CN; Blum CB; Eckel RH; Goldberg AC; Gordon D; Levy D; Lloyd-Jones DM; McBride P; Schwartz JS; Shero ST; Smith SC; Watson K; Wilson PW; Eddleman KM; Jarrett NM; LaBresh K; Nevo L; Wnek J; Anderson JL; Halperin JL; Albert NM; Bozkurt B; Brindis RG; Curtis LH; DeMets D; Hochman JS; Kovacs RJ; Ohman EM; Pressler SJ; Sellke FW; Shen WK; Smith SC; Tomaselli GF;
Circulation; 2014 Jun; 129(25 Suppl 2):S1-45. PubMed ID: 24222016
[No Abstract] [Full Text] [Related]
5. Perspective on the 2013 American Heart Association/American College of Cardiology guideline for the use of statins in primary prevention of low-risk individuals.
Breslow JL
Circ Res; 2014 Feb; 114(5):758-60. PubMed ID: 24577963
[No Abstract] [Full Text] [Related]
6. Towards a Paradigm Shift in Cholesterol Treatment. A Re-examination of the Cholesterol Issue in Japan.
Hamazaki T; Okuyama H; Ogushi Y; Hama R
Ann Nutr Metab; 2015; 66 Suppl 4():1-116. PubMed ID: 25925499
[No Abstract] [Full Text] [Related]
7. Comparative long-term efficacy and tolerability of pitavastatin 4 mg and atorvastatin 20-40 mg in patients with type 2 diabetes mellitus and combined (mixed) dyslipidaemia.
Gumprecht J; Gosho M; Budinski D; Hounslow N
Diabetes Obes Metab; 2011 Nov; 13(11):1047-55. PubMed ID: 21812889
[TBL] [Abstract][Full Text] [Related]
8. How aggressively should cholesterol targets be pursued?
Wierzbicki AS
Br J Hosp Med (Lond); 2007 May; 68(5):232-3. PubMed ID: 17554938
[No Abstract] [Full Text] [Related]
9. The 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guidelines on the Management of Blood Cholesterol in Diabetes.
Goldberg RB; Stone NJ; Grundy SM
Diabetes Care; 2020 Aug; 43(8):1673-1678. PubMed ID: 32669405
[TBL] [Abstract][Full Text] [Related]
10. Treatment options for low high-density lipoproteins.
Hafiane A; Kellett S; Genest J
Curr Opin Endocrinol Diabetes Obes; 2014 Apr; 21(2):134-9. PubMed ID: 24535232
[TBL] [Abstract][Full Text] [Related]
11. Very High-Risk ASCVD and Eligibility for Nonstatin Therapies Based on the 2018 AHA/ACC Cholesterol Guidelines.
Virani SS; Akeroyd JM; Smith SC; Al-Mallah M; Maddox TM; Morris PB; Petersen LA; Ballantyne CM; Grundy SM; Stone NJ
J Am Coll Cardiol; 2019 Aug; 74(5):712-714. PubMed ID: 31370962
[No Abstract] [Full Text] [Related]
12. Merits and potential downsides of the 2013 ACC/AHA cholesterol management guidelines.
Gotto AM; Moon JE
Nutr Metab Cardiovasc Dis; 2014 Jun; 24(6):573-6. PubMed ID: 24819819
[TBL] [Abstract][Full Text] [Related]
13. Four Cases of Cholesterol Management Informed by the 2018 American Heart Association/American College of Cardiology Multisociety Guideline on the Management of Blood Cholesterol.
Chuzi S; Pfenniger A; Lloyd-Jones DM; Blumenthal RS; Smith SC; Virani SS; Grundy SM; Stone NJ
JAMA Cardiol; 2019 May; 4(5):473-477. PubMed ID: 30969319
[TBL] [Abstract][Full Text] [Related]
14. 2018 American Heart Association/American College of Cardiology/Multisociety Guideline on the Management of Blood Cholesterol-Secondary Prevention.
Grundy SM; Stone NJ
JAMA Cardiol; 2019 Jun; 4(6):589-591. PubMed ID: 30994869
[No Abstract] [Full Text] [Related]
15. New Studies Do Not Challenge the American College of Cardiology/American Heart Association Lipid Guidelines.
Hofer TP; Sussman JB; Hayward RA
Ann Intern Med; 2016 May; 164(10):683-4. PubMed ID: 26857151
[No Abstract] [Full Text] [Related]
16. 2018 American Heart Association/American College of Cardiology Multisociety Guideline on the Management of Blood Cholesterol: Primary Prevention.
Grundy SM; Stone NJ
JAMA Cardiol; 2019 May; 4(5):488-489. PubMed ID: 30969322
[No Abstract] [Full Text] [Related]
17. [Statin treatment in type 2 diabetes. Is it a must today?].
Faust M
MMW Fortschr Med; 2003 Feb; 145(9):35-6. PubMed ID: 12666527
[No Abstract] [Full Text] [Related]
18. [Screening for hyperlipidemia in cardiovascular high-risk patients in austrian diabetes ambulances].
Brath H; Wascher TC; Kästenbauer T; Toplak H
MMW Fortschr Med; 2012 Jun; 154 Suppl 2():41-7. PubMed ID: 23424754
[TBL] [Abstract][Full Text] [Related]
19. What is new in the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic risk in adults?
Virani SS
Tex Heart Inst J; 2014 Jun; 41(3):304-5. PubMed ID: 24955047
[No Abstract] [Full Text] [Related]
20. Effect of treatment with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on serum coenzyme Q10 in diabetic patients.
Miyake Y; Shouzu A; Nishikawa M; Yonemoto T; Shimizu H; Omoto S; Hayakawa T; Inada M
Arzneimittelforschung; 1999 Apr; 49(4):324-9. PubMed ID: 10337451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
